Soleno Therapeutics Inc. buy Laidlaw
Start price
27.03.25
/
50%
€61.65
Target price
27.03.26
€97.53
Performance (%)
-58.18%
End price
28.03.26
€25.78
Summary
This prediction ended on 28.03.26 with a price of €25.78. Massive losses of -58.18% were the result for the BUY prediction by Laidlaw. Laidlaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Soleno Therapeutics Inc. | -0.314% | -0.314% | -29.723% |
| iShares Core DAX® | -1.424% | 8.918% | 7.311% |
| iShares Nasdaq 100 | 3.274% | 16.275% | 36.651% |
| iShares Nikkei 225® | 1.745% | 16.239% | 46.602% |
| iShares S&P 500 | 1.447% | 10.913% | 27.166% |
Comments by Laidlaw for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Laidlaw from $75.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat
In the thread Trading Soleno Therapeutics Inc.
Die von Laidlaw gewählte maximale Laufzeit wurde überschritten